Hypertension, or high blood pressure, is a major risk factor for heart disease, the leading cause of death in the United States. Approximately 1 in 3 American adults has high blood pressure, but this condition is even more prevalent among African Americans. 1 Despite its large health impact, primary prevention of hypertension is hampered partly due to a limited knowledge of risk factors for this condition. Recent observational evidence suggests that low levels of 25-hydroxyvitamin D 
Background
Several observational studies have recently suggested an inverse association of circulating levels of vitamin D with blood pressure. These findings have been based mainly on Caucasian populations; whether this association also exists among Hispanic and african americans has yet to be definitively determined. This study investigates the association of 25-hydroxyvitamin D (25[OH]D) with blood pressure in Hispanic and african americans.
methodS
The data source for this study is the Insulin Resistance atherosclerosis Family Study (IRaSFS), which consists of Hispanic-and africanamerican families from three US recruitment centers (n =1,334). a variance components model was used to analyze the association of plasma 25[OH]D levels with blood pressure. reSultS an inverse association was found between 25[OH]D and both systolic (β for 10 ng/ml difference = −2.05; P < 0.01) and diastolic (β for 10 ng/ ml difference = −1.35; P < 0.001) blood pressure in all populations combined, after adjusting for age, sex, ethnicity, and season of blood draw. Further adjustment for body mass index (BMI) weakened this association (β for 10 ng/ml difference = −0.94; P = 0.14 and β for 10 ng/ml difference = −0.64; P = 0.09, respectively). concluSionS 25[OH]D levels are significantly inversely associated with blood pressure in Hispanic and african americans from the IRaSFS. However, this association was not significant after adjustment for BMI. Further research is needed to determine the role of BMI in this association. Large, well-designed prospective studies of the effect of vitamin D supplementation on blood pressure may be warranted. 13 Additional probands were ascertained from the general population. Criteria for proband selection were based on large family size, not on disease status or extreme phenotypes. Participants who reported taking antihypertensive medication (n = 196) were excluded from the analyses in this report. A total of 1,334 participants with information on blood pressure and 25[OH]D levels were included in the analyses. This research has been approved by the institutional review board at each institution and informed consent was obtained from all subjects.
Measurement of blood pressure. Resting seated blood pressure was measured three times at a single study visit using a mercury sphygmomanometer, after a 5-min rest by centrally trained technicians using identical equipment. Blood pressure technicians participated in monthly reproducibility studies within center, and the inter-rater coefficient of variation for repeat diastolic and systolic blood pressure measures among 22 pairs of readings was 3 and 2%, respectively. The mean of the last two measurements was used to calculate blood pressure. 
Measurement of covariates.
For the purpose of the analysis, blood draws taken from December through May were categorized as winter/spring and all others as summer/fall samples. Body mass index (BMI) was calculated as weight/ height 2 (kg/m 2 ). Hispanic-or African-American ethnicity was self-reported. As previously reported, 12 physical activity was assessed by a 1-year recall using a modification of a validated instrument 14 that incorporated activities common among IRASFS participants, including ranching and homemaking activities. Total energy expended (in kcal/kg) per year was calculated by summing across all activity groups, plus the estimated energy expenditure from sleep (metabolic equivalent value of 1.0), plus the estimated energy expenditure from light activities (e.g., sitting metabolic equivalent value of 1.5). Gender-specific quartiles of physical activity were calculated. Smoking status was self-reported as never ("Have you smoked at least 100 cigarettes in your lifetime" answered "No"), past ("Have you smoked at least 100 cigarettes in your lifetime" answered "Yes", but participant does not currently smoke), or current.
Statistical analyses. The analyses were conducted using a generalized estimating equations model via the GENMOD procedure in the SAS software version 9.1 (SAS Institute, Cary, NC). Familial correlation was accounted for by using a sandwich estimator of the variance and exchangeable correlation. There was no significant interaction between study center and blood levels of 25[OH]D (P for interaction term = 0.31 for systolic and 0.99 for diastolic blood pressure); so all centers were combined for the analyses. The following variables were included in the initial model as potential covariates: gender, age, ethnicity, season of blood draw, BMI, physical activity, and smoking status. A backward stepwise regression was performed, starting with this initial model.
reSultS
A total of 1,334 participants from 130 families (mean family size = 10.2; range = 1-42) were included in the analyses. The mean age of the participants was 38.5 (range = 18-81). The mean 25[OH]D for these Hispanic-and African-American participants was quite low (14.8 ng/ml, which is considered to be vitamin D deficient; discussed in detail previously 12 
Vitamin D and Blood Pressure in Blacks and Hispanics
indicating that the association between 25[OH]D levels and blood pressure is similar in the Hispanic-and AfricanAmerican populations in this study, which was confirmed by race-stratified analyses (data not shown).
diScuSSion
Our results suggest that circulating 25[OH]D concentrations are inversely associated with systolic and diastolic blood pressure in Hispanic and African Americans, but the effect is weakened after adjusting for BMI. This finding supports those from a nationally representative study including Hispanic and African Americans. 4 If the inverse association between 25[OH]D and blood pressure could be replicated using an observational longitudinal study design or a randomized clinical trial, it could have public health significance, as the potential influence of raising 25[OH]D levels to sufficiency could substantially lower blood pressure. For example, raising 25[OH]D levels of individuals in the lowest quintile of 25[OH]D in this study (~8 ng/ml) to levels of the highest quintile (~32 ng/ml, a sufficient level of vitamin D) could potentially lower systolic blood pressure by 2.3 mm Hg and diastolic blood pressure by 1.5 mm Hg ( estimates based on models including BMI). As noted by Scragg et al., 4 a decrease in systolic blood pressure of this magnitude would be estimated to produce an ~10-15% decline in cardiovascular mortality. However, as stated earlier, additional studies with a longitudinal study design are needed to confirm the causative effect of 25[OH]D levels on blood pressure. Only one large prospective randomized study has looked at the effect of vitamin D supplementation on blood pressure thus far. 15 No effect was detected in that study, possibly due to several factors previously described, 16 including the possibility of unequal proportions of participants in the treatment and placebo groups on antihypertensive medication during follow-up and the dosage level of vitamin D being too low to have an effect on blood pressure. Additionally, the effect of vitamin D supplementation on 25[OH]D levels was not reported.
The interpretation of the association between 25[OH]D levels and blood pressure depends on whether it is appropriate to adjust for BMI. Scragg et al. described evidence suggesting that BMI may be an intermediate step in the vitamin D-blood pressure causal pathway and therefore it should not be adjusted for. 4 The lower levels of 25[OH]D typically seen [21] [22] [23] The exclusion of participants on antihypertensive medication could have introduced a bias in our results. However, results from analyses investigating an association of 25[OH]D levels with baseline hypertension (defined as having either systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg or currently taking antihypertensive medication) supported the inverse directionality of the association of 25[OH]D with blood pressure, although the association was not significant (P > 0.05, data not shown). An additional limitation is that a relatively small proportion of the participants included in the analyses had high blood pressure (72 out of 1,334 (5%) had a systolic blood pressure ≥140 mm Hg and 93 (7%) had a systolic blood pressure ≥90 mm Hg). Consequently, even though there was a trend toward a lower mean 25[OH]D as systolic blood pressure increased (Table 1) , the results were not significant for the group with systolic blood pressure ≥140 mm Hg, which could be due to a small sample size in this group.
This study shows an inverse association between vitamin D status, measured by 25[OH]D, and blood pressure in Hispanicand African-American populations, after adjustment for several potentially confounding variables; although this association was not significant after adjustment for BMI. This finding could potentially have important public health implications, as increased vitamin D levels can be easily attained by vitamin D supplementation, or modest sun exposure. However, this type of intervention should be supported by the results of large, well conducted, randomized intervention trials of vitamin D supplementation.
